These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 2870962)

  • 21. [Hemodynamic and humoral effects of fendiline, a calcium antagonist drug, in idiopathic hypertension patients].
    Castellano M; Beschi M; Muiesan ML; Romanelli G; Muiesan G
    Cardiologia; 1984; 29(7-8):359-66. PubMed ID: 6542415
    [No Abstract]   [Full Text] [Related]  

  • 22. [Value of fendiline in the treatment of patients with stable angina pectoris].
    Markiewicz M; Wysokiński A; Rymar B; Trojnar R
    Pol Tyg Lek; 1987 Nov; 42(46):1456-8. PubMed ID: 3328180
    [No Abstract]   [Full Text] [Related]  

  • 23. Effect of Sensit (fendiline) in angina pectoris.
    Böszörményi E; Ludvigh K; Fehér G; Schwarz J; Kármán M; Sziebert P
    Ther Hung; 1981; 29(3):134-7. PubMed ID: 7188139
    [No Abstract]   [Full Text] [Related]  

  • 24. Clinical application of Sensit.
    Pálossy B
    Ther Hung; 1981; 29(4):171-5. PubMed ID: 6765146
    [No Abstract]   [Full Text] [Related]  

  • 25. [Effect of the calcium antagonist fendiline on digitalis-induced ischemic reactions in the ECG].
    Kababgi MD; Schneider KW; Deeg P
    Med Welt; 1980 Jun; 31(25):959-62. PubMed ID: 7421525
    [No Abstract]   [Full Text] [Related]  

  • 26. [Effect of fendiline on left-ventricular function evaluated by the echocardiographic method and on physical work capacity of patients with stable angina pectoris].
    Markiewicz M; Wysokiński A; Rymar B; Trojnar R; Wójcik J; Sokoluk I
    Wiad Lek; 1987 Dec; 40(24):1664-8. PubMed ID: 3451600
    [No Abstract]   [Full Text] [Related]  

  • 27. Fendiline: a review of its basic pharmacological and clinical properties.
    Bayer R; Mannhold R
    Pharmatherapeutica; 1987; 5(2):103-36. PubMed ID: 3310016
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of Sensit (fendiline) in the light of new data.
    Szám L; Tardos L
    Ther Hung; 1987; 35(1):19-22. PubMed ID: 3326203
    [No Abstract]   [Full Text] [Related]  

  • 29. [Effective vasodilation. The calmodulin key molecule].
    Busse R
    Fortschr Med Suppl; 1986; 3():12-3. PubMed ID: 2870961
    [No Abstract]   [Full Text] [Related]  

  • 30. [Evaluation of the calcium antagonist fendilin in exertion angina].
    Fino E; Colonna L
    Clin Ter; 1985 Mar; 112(5):445-51. PubMed ID: 3893860
    [No Abstract]   [Full Text] [Related]  

  • 31. Intracellular localization of the calcium- and calmodulin antagonist fendiline.
    Weyhenmeyer R; Gross M; Maurer-Schultze B
    Arzneimittelforschung; 1989 Feb; 39(2):199-201. PubMed ID: 2730688
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Calcium antagonists (finoptin and senzit) in the treatment of cerebrovascular disorders].
    Burtsev EM; Savkov VS
    Klin Med (Mosk); 1989 Sep; 67(9):51-4. PubMed ID: 2586041
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Examination of the anti-anginous effect of Sensit in angina pectoris.
    Tóth K
    Ther Hung; 1986; 34(4):212-6. PubMed ID: 3449975
    [No Abstract]   [Full Text] [Related]  

  • 34. [At issue: vascular spasms. Calmodulin antagonism to intracellular calcium].
    Rüegg JC
    Fortschr Med Suppl; 1986; 3():5-7. PubMed ID: 2870965
    [No Abstract]   [Full Text] [Related]  

  • 35. [Causes and treatment of coronary failure].
    Kutscha W
    Fortschr Med Suppl; 1986; 3():15-8. PubMed ID: 2870963
    [No Abstract]   [Full Text] [Related]  

  • 36. [Hemodynamic changes during treatment with isodinit, sectral, stenopril and kratemon].
    Stankusheva G; Draganov V; Manolov P
    Vutr Boles; 1987; 26(2):33-8. PubMed ID: 3604194
    [No Abstract]   [Full Text] [Related]  

  • 37. [Calcium antagonists and adenosine derivatives in the treatment of patients with chronic ischemic heart disease].
    Kuz'ko NV
    Vrach Delo; 1988 Oct; (10):16-9. PubMed ID: 3218185
    [No Abstract]   [Full Text] [Related]  

  • 38. [Indications for use of calcium antagonists].
    Lehmann HU; Hochrein H
    Med Klin; 1980 Apr; 75(8):288-94. PubMed ID: 6993902
    [No Abstract]   [Full Text] [Related]  

  • 39. [Ildamen in the treatment of coronary heart disease].
    Markiewicz M; Bielak J; Zminkowska U
    Pol Tyg Lek; 1972 Jul; 27(30):1176-8. PubMed ID: 5073030
    [No Abstract]   [Full Text] [Related]  

  • 40. Enhancement of the cytogenetic efficacy of the antitumor agent bleomycin by the calcium and calmodulin antagonist fendiline.
    Scheid W; Traut H
    Experientia; 1988 Mar; 44(3):228-30. PubMed ID: 2450775
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.